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Conservative management of residual and 
recurrent lesions after carotid 
endarterectomy: Long-term results 
John J. Ricotta, MD, and Monica S. O'Brien-Irr ,  MS, RN, Stony Brook, N.Y. 
Purpose: To document the natural history of residual and recurrent carotid stenoses that 
are initially treated without surgery, and to identify risk factors for recurrent stenosis. 
Methods: Review of data from a prospective carotid database with clinical and duplex 
follow-up. Analysis of rate of restenosis and rate of late reoperation by life table. Risk 
factor analysis by X 2 and LEE-DESU statistics. 
Results: Three hundred forty-eight patients were available for follow-up, with 12 residual 
lesions (3.7%) and 22 recurrent lesions (6.6%). Rate of recurrent stenosis by life table 
analysis was 8.7% and 13% at 3 and 5 years. Restenosis was associated with smoking (p = 
0.04) and contralateral progression. Only 21% of patients were underwent an operation 
within 5 years (p = 0.007) of restenosis developing, but eventually 10 of 22 patients 
required reoperation atlong-term follow-up, eight for symptoms and two for progressive 
proximal stenoses. The late stroke rate was increased in patients who had residual or 
recurrent lesions compared with those who had normal duplex study results (18% vs 6%; 
p = 0.16) and was related to the ipsilateral artery. 
Conclusions: Recurrent lesions that remain asymptomatic can be managed without oper- 
ation with likelihood of success in the near term (5 years). However, these patients are at 
increased risk of late stroke, and almost half will eventually require operation. Therefore, 
in good-risk patients operation for asymptomatic restenoses hould be considered. 
(J Vase Surg 1997;26:963-72.) 
Carotid endarterectomy has been established as 
the gold standard for patients with severe (>70%) 
stenoses of the carotid bifurcation. Many studies 
have documented that this operation can be per- 
formed with minimal morbidity and mortality risks. 
Despite its success, residual stenoses are found in a 
small number of patients after endarterectomy, and 
recurrent lesions develop in a subset of  patients on 
long-term follow-up. The proper management of 
these lesions is subject to debate. Several authors 
documented an increased risk with secondary opera- 
tions for carotid stenosis, 1 2 whereas others have re- 
ported series with complication rates that are not 
significantly different from those of primary endarter- 
ectomy. 3-6 The indications for reoperation vary be- 
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tween surgeons; ome advocate routine operation for 
severe stenosis, whereas others, including our- 
selves, 7d° have adopted a more conservative ap- 
proach because of the low incidence of symptomatic 
recurrence ven with severe lesions. In most opera- 
rive series, one third to one half of operated lesions 
are asymptomatic. There are no long-term prospec- 
tive data on the results of managing asymptomatic 
recurrent stenosis expectantly. The purpose of this 
review was to document the late outcome of patients 
with recurrent and residual stenosis initially managed 
without operation, with particular attention to the 
rate of reoperation, the late stroke rate, and the 
morbidity of secondary carotid reconstruction. 
MATERIALS  AND METHODS 
We reviewed all carotid endarterectomy proce- 
dures performed by a single surgeon that had been 
entered prospectively into a carotid database. Pa- 
tients were prospectively followed-up with reference 
to development ofnew neurologic symptoms as well 
as evidence of recurrent stenosis by duplex ultra- 
sound. Patients who had both clinical and duplex 
ultrasound follow-up were selected for further analy- 
sis. Residual or recurrent stenoses were identified on 
963 
JOURNAL OF VASCULAR SURGERY 
964 Ricotta and O'Brien-lrr December 1997 
Table I. Patient characteristics 
Excluded 
Study group patients 
Indicator (n = 348) (n = 95) p 
Patient age (yr) 68.1 _+ 8.5 68.1 + 8.2 NS 
Male 53.2% 64.5% 0.05* 
Coronary artery disease 51.9% 43.4% 0.19 
Hypertension 74.3% 72.0% 0.68 
Diabetes mellitus 31.7% 29.6% 0.72 
Smoking 43.4% 64.1% 0.001" 
Asymptomatic 38.9% 30.7% 0.115 
Bilateral disease at time of 39.1% 50.0% 0.45 
surgery 
Postoperative 2.0% 9.7% <0.001 
cerebrovascular accident 
Late stroke-free rate (3 yr) 94.6% 91.9% 
Late stroke-free rate (5 yr) 92.7% 92.7% 0.95 
*Statistically significant. 
the basis of elevations in peak systolic velocity using 
criteria validated in our laboratory. The incidence of 
residual and recurrent lesions was determined in the 
study group. Lesions that caused >50% diameter 
stenosis by duplex ultrasound were defined as signif- 
icant and were further divided into moderate (50% to 
74%), severe (75% to 99%), and occluded groups. 
Based on our previous report, 7 residual esions are 
defined as those that appeared on the first postoper- 
ative study performed within 12 months of endarter- 
ectomy. Recurrent stenoses are defined as those that 
appeared subsequent to a normal duplex examina- 
tion or more than 12 months after the initial exami- 
nation. The risk ofrestenosis for the study group was 
calculated at 3 and 5 years by life table methods. 
Patients who had asymptomatic residual or recurrent 
lesions were initially followed-up without operation 
on the basis of our prior published experience. 7 In 
patients who had residual and recurrent lesions, the 
number of late reoperations and the rate of reopera- 
Lion was determined. Finally, the late stroke rate of 
patients with residual and recurrent lesions was com- 
pared with that of patients without such lesions, and 
the complications associated with secondary opera- 
tion were documented. For this final analysis, wc 
reviewed the results of all secondary operations per- 
formed during the review period, including those in 
patients whose primary operation was performed 
elsewhere. 
RESULTS 
A total of 443 patients was entered into the data- 
base between 1982 and 1996. The overall perioper- 
ative stroke and death rate was 2.3%. Long-term 
clinical and duplex follow-up was available in 348 
Table II. Residual lesions (n = 13) 
Location 50% to 74% 75% to 99% Occluded Total 
Common carotid 1 0 1 2 
artery 
Internal carotid 1 7 3 11 
artery 
Total 2 7 4 13 
cascs, which form the basis for the remainder of this 
report. Duplex follow-up was not available in 95 
patients. Many of these patients underwent opera- 
tion in the early experience before an established 
ultrasound protocol existed. When compared with 
the study group, patients without follow-up were 
morc likely to smoke (p = 0.001) and had a higher 
perioperative stroke rate (p < 0.001). The data are 
shown in Table I. Clinical followiup was available in 
81 of these patients, and the late stroke rate did not 
differ from that of the study group. There were 13 
residual lesions identified in the study group (3.7%), 
including five postoperative occlusions. A listing of 
these lesions and their location and severity is pre- 
sented in Table II. Duplex evidence of recurrent 
stenosis was seen in 22 patients (6.6%). Ten patients 
(2.9%) had evidence of a stenosis of  50% to 79%. 
Severe lesions developed in 12 patients (3.7%), in- 
cluding one late occlusion. The risk of restenosis 
>50% developing after primary endarterectomy was 
8.7% at 3 years and 13% at 5 years by life table 
analysis and is presented in Fig. 1. We evaluated the 
potential effect of gender, smoking history, and patch 
closure on the development of  recurrent stenosis, 
and only smoking history was significant (p < 0.04; 
Table III). The development of restenosis was asso- 
ciated with progression of disease in the contralateral 
carotid artery (p = 0.007; LEE-DESU). In patients 
who did not have contralateral disease progression, 
the risk of developing a recurrent stenosis was 6% at 3 
years and 12.77% at 5 years, compared with 25.3% at 
both 3 and 5 years in patients who had contralateral 
progression (Fig. 2). 
The initial management of residuai and recurrent 
lesions was nonoperative in all cases. Our initial strat- 
egy of nonoperative management was successful in 
most cases; only 14.2% of recurrent lesions were 
operated on within 3 years of their development, 
with 20.6% eventually operated on by 5 years of 
follow-up. These data are presented graphically in 
Fig. 3. One patient mderwent secondary operation 
for a severe asymptomatic ulcerated residual lesion i  
the common carotid artery. The remainder of  resid- 
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Fig. 1. Restenosis-free rate in 334 patients who underwent long-term Doppler evaluation 
after carotid endarterectomy, excluding postoperative occlusion and residual stenosis, reveals 
restenosis rates of 8.7% and 13% at 3 and 5 years, respectively. 
ual lesions were followed-up. Reoperation for recur- 
rent stenosis was more frequent. Eventually, 10 of  
the 22 arteries with recurrent lesions came to reop- 
eration (47.8%). Indications for reoperation in pa- 
tients with recurrent lesions included symptoms in 
eight patients, whereas two patients were asymptom- 
atic at operation. These patients both had progres- 
sive asymptomatic common carotid artery stenoses 
outside the original endarterectomy site. 
Neurologic symptoms developed during fol- 
low-up in four of  the 13 patients who had residual 
disease (one transient and three permanent) and in 
nine of the 22 patients who had recurrent lesions (six 
transient and three permanent). Development of 
neurologic symptoms with restenosis was not related 
to the patients' neurologic status before the initial 
endarterectomy. With one exception, all neurologic 
symptoms were ipsilateral to the residual or recurrent 
lesion. The late stroke rate was increased in patients 
who had residual or recurrent lesions compared with 
those who had no significant ipsilateral disease after 
carotid endarterectomy (18% vs 6% at 5 years), al- 
though this did not reach statistical significance (p = 
0.16 by LEE-DESU). 
To determine the complication rate after carotid 
reoperation, we examined our entire experience with 
secondary carotid operations. During this time pe- 
Table I I I .  Correlation between potential 
risk factors and recurrent stenosis 
Factors Rate of rea-tenosis p 
Male gender 5.9% (11 of 155) 0.59 
Female gender 7.4% (12 of 150) 
Primary closure 6.6% (5 of 76) 0.98 
Patch closure 6.6% (18 of 271) 
Smoker 10.4% (14 of 134) 0.04 
Nonsmoker 4.5% (8 of 178) 
riod, a total of 15 operations were performed for 
recurrent carotid stenosis, including five in patients 
whose primary procedure was performed elsewhere. 
There were a total of three neurologic deficits (20%); 
two were permanent, and one resolved within 30 
days. All three of these lesions were consistent with a 
watershed infarction on computed tomographic ex- 
amination, and patency of  the carotid artery was 
documented by angiogram. In two of  these patients 
perioperative hypotension was documented, whereas 
the third patient was having crescendo transient isch- 
emic attacks and could not be shunted. There were 
two patients who had evidence of cranial nerve dys- 
function after reoperation (12.5%). In both cases, 
this dysfunction involved dysphagia nd eventually 
resolved. 
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Fig. 2. Restenosis-free rate after carotid endarterectomy in 308 patients without progressive 
contralateral disease compared with 26 patients With contralateral progressive disease during 
follow-up is statistically significant (6% at 3 years vs 25.3% at 3 and 5 years; p = 0.007). 
DISCUSSION 
Carotid endarterectomy has been established as 
the gold standard for treatment of severe bifurcation 
stenosis on the basis of  the results of  prospective 
randomized trials. 11-14 Although safe and highly suc- 
cessful, this operation is clearly associated with a 
small but real incidence of residual or recurrent ste- 
nosis. The incidence of such lesions has been esti- 
mated between 6% and 18% by various authors and 
depends on whether stenosis is detected by angiog- 
raphy or duplex scanning and whether outine fol- 
low-up ofasymptomatic patients after CEA is done. 6- 
~0,15-~8 Those who report the highest incidence of 
abnormalities base their conclusions on disturbances 
in Doppler flow velocity, 16 about half of which nor- 
malize over time. Reoperation for ipsilateral symp- 
toms associated with recurrent stenosis after carotid 
endarterectomy is considerably less frequent than 
asymptomatic stenosis; the incidence approximates 
1% to 2%. In our own series of 348 patients, there 
were eight reoperations for symptoms (2.3%). This 
has led most clinicians to the conclusion that the 
majority of  recurrent stenoses will remain asymptom- 
atic, particularly if they are the result of  neointimal 
hyperplasia. In 1992, 7we reported our initial obser- 
vations on recurrent and residual stenoses and sug- 
gested that the majority of lesions could be fol- 
lowed-up for prolonged periods without operation, a 
position supported by Sumner and others. 8-~° Other 
investigators have been more liberal in their surgical 
indications and advocate reoperation for severe le- 
sions (> 80% diaaneter reduction) even when asymp- 
tomatic. 4-6,19 This issue is of some importance be- 
cause the risk of reoperation has been reported by 
some, but not others, to be increased over that of 
primary operation. In 1985, Das et al. 1 from the 
Cleveland Clinic reported on 65 carotid reoperations 
with a combined stroke and death rate of 4.6% and 
an incidence of cranial nerve deficits of 9.2%. Shortly 
thereafter, Piepgras et al? from the Mayo Clinic 
reported 57 reoperations in 51 patients with an op- 
erative compfication rate of 10.5 % ( 1986), which was 
a fourfold increase over their complication rate for 
primary operation. In a more recent survey by the 
Southern Association for Vascular Surgery, 
Rosenthal et al.z0 identified 31 patients who under- 
went secondary reoperation without stroke or death, 
but with a 10% rate of peripheral nerve injury. Con- 
temporary series from New England Medical Cen- 
ter, 4,21 Dallas, 6 and New York s have reported mor- 
bidity rates that approach those of primary operation. 
Most recently, the issue has been further complicated 
by assertions that recurrent stenosis is an indication 
for endovascular therapy. Initial reports with angio- 
plasty alone have been disappointing, with complica- 
tion rates as high as 33%, but more recent reports of 
angioplasty with stent placement are more encourag- 
ing. 22-24 
There is a lack of objective data on the long-term 
follow-up of  patients with recurrent carotid stenoses. 
Such data are important to allow informed ecisions 
as to when intervention for recurrent stenosis is indi- 
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Fig. 3. Interval to reoperation i 23 patients with recurrent stenosis reveals 21% reoperation 
rate at 5 years. Although the numbers of patients followed-up more than 5 years is small, the 
slope of the curve suggests progressive incidence of reoperation after prolonged follow-up. 
Eventually, 48% of our patients required reoperation. 
cated, as well as to provide a benchmark for opera- 
tion and endovascular therapy. For many years our 
initial approach to residual and recurrent lesions has 
been nonoperative, and this was reinforced by our 
earlier review. 7 The purpose of this report was to 
provide prolonged follow-up of  a cohort with signif- 
icant lesions that were managed conservatively b  a 
single surgeon. We specifically wished to address the 
frequency of such lesions, the rate of late reoperation 
and its complications, and the incidence of late symp- 
toms in patients with residual or recurrent disease. 
Our study group included 78.3% of our total popu- 
lation (347 of  443). It is important to remember that 
of  the 95 patients excluded, 81 had clinical follow-up 
but were excluded because of the lack of duplex data. 
This is an acknowledged problem of retrospective 
reviews over long periods of  time and always raises 
questions concerning the accuracy of our conclu- 
sions. In an effort o answer these concerns, we com- 
pared the groups with and without follow-up. These 
comparisons merit some comment. Male gender and 
smoking were more common in patients who did not 
have follow-up. The association between smoking 
and restenosis suggests that the incidence ofresteno- 
sis may bc understated by our study population. 
Perioperative stroke was seen in 10% of patients with- 
out follow-up, most of  whom underwent operation 
before 1988. This probably reflects more residual 
lesions in the group without follow-up. However, if 
patients after 1987 are compared, there is no differ- 
ence in perioperative stroke rate between patients 
who were excluded for lack of duplex follow-up and 
those in the study group. This suggests that our data 
on residual lesions reflect contemporary results. 
These issues are of only secondary importance to the 
focus of this paper, which is on the long-term results 
of nonoperative treatment in patients who have 
proven lesions. In this regard, the long-term stroke 
rate in the 81 patients who were excluded for lack of 
duplex examination but had clinical follow-up is im- 
portant. There was no difference in the late stroke 
rate in patients with and without duplex follow-up 
(p = 0.95 by life table). This provides assurance that 
the major conclusion of  our studies are valid. We 
believe that these analyses uggest that the basic 
conclusions of our study were not altered by the lack 
of complete foflow-up in all patients. 
The incidence of residual lesions after carotid 
endarterectomy was 3.7%, which is not significantly 
different from that in our earlier eport. These l sions 
were found at both the proximal and distal ends of 
the endarterectomy. In an attempt o decrease the 
incidence of residual proximal disease, we have more 
recently extended our endarterectomy ore proxi- 
mally in the common carotid artery, even to the 
point of a subclavian-to-carotid bypass graft in one 
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instance. The problem of proximal carotid plaque has 
been noted by several authors. 2a,26 Although we have 
not used the modification suggested by Arch ie  26 to  
address this problem, it appears to have merit. As 
recently reported, we do not routinely use comple-- 
tion imaging after endarterectomy. 27 Our own data 
suggest hat the occurrence of residual esions was 
associated primarily with long or difficult endarterec- 
tomy procedures and is unlikely to be affected by 
routine imaging. 27 Several authors uggest that rou- 
tine completion imaging would reduce the incidence 
of both residual and recurrent disease. 28,29 We are 
unable to determine whether routine imaging would 
have further educed our overall incidence of recur- 
rent disease, which was seen in 6.6% of patients and 
compares with that reported in the literature, but we 
believe that this is the best argument available for 
completion imaging. 
Factors that have been suggested to be associated 
with an increased incidence of recurrent stenosis in- 
clude smoking, female gender, and primary clo- 
sure. 7'3°'31 We did not find any association with gen- 
der or primary closure, although our high incidence 
of patch closure (77.5%) may have precluded etect- 
ing such a relationship. The lack of gender effect hat 
has been reported by others is probably aresult of the 
very frequent use of patch closure, which has been 
advocated in women. A history of smoking was asso- 
~ciated with an increased incidence of recurrent dis- 
ease. Along with the strong association between re- 
current stenosis and the progression of contralateral 
disease (p < 0.007), this supports the premise that 
uncontrolled progressive atherosclerosis is a com- 
mon denominator in patients who have recurrent 
lesions. One other report, by Cantelmo et al., 32 
noted an increased incidence ofrestenosis n patients 
who had bilateral disease, which supports our obser- 
vations. Our data showed a progressive risk of reste- 
nosis over time, with many patients requiting reop- 
eration after being observed for recurrent lesions 
after follow-up of more than 5 years. These data 
emphasize the importance of late follow-up in pa- 
tients with recurrent disease and point to the role 
played by progressive atherosclerosis rather than inti- 
mal hyperplasia n the development of symptomatic 
lesions. 
Our policy of watchful waiting appeared justified 
during the early follow-up of our patients; only one 
residual lesion required operation, and 79% of recur- 
rent lesions could be observed for 5 years after devel- 
opment (life table analysis). This finding was consis- 
tent with our cartier published observations. However, 
symptoms eventually developed in 39% of our pa- 
tients on prolonged follow-up, and 47% (11 of 23) 
ultimately required reoperation. These data are the 
first to document he extended natural history of 
recurrent stenosis in a cohort of patients in whom 
recurrent stenosis is identified by prospective routine 
screening. Our data indicate that more than one 
third of these lesions will eventually become symp- 
tomatic. This high incidence of late symptoms from 
recurrent stenosis is also consistent with the hypoth- 
esis that most of these lesions that become symptom- 
atic represent recurrent atherosclerosis rather than 
intimal hyperplasia. The increased late stroke risk in 
this group of patients uggests that we may have 
been too conservative in recommending reoperation 
to these patients. 
Our data bear some relevance to the current de- 
bate over the appropriateness of carotid angioplasty 
and stenting in patients in whom recurrent stenosis 
develops. The low reoperation rate at 3 and 5 years 
again emphasizes that most lesions, particularly early 
ones, will remain asymptomatic in the near term. We 
believe that early intervention i  asymptomatic pa- 
tients should not be undertaken lightly, particularly 
in high-risk patients who may have a limited life 
expectancy. This is particularly true when an investi- 
gational technique with unknown durability is used. 
Our personal results with recurrent operation are 
sobering, although the absolute number of opera- 
tions is not large. We believe that these results must 
be interpreted in light of our strict criterion for reop- 
eration, where 13 of 16 lesions were symptomatic 
(including one patient with crescendo transient isch- 
emic attacks). In our patients, postoperative neuro- 
logic complications were related to hypoperfusion 
and not occlusion of the endarterectomy site. Results 
of larger contemporary series reported by oth- 
ers 4,s,6,2°,21 indicate that reoperation can be under- 
taken with considerably less risk than was reported in 
the mid-1980s and than was seen in our own series. 
Future evaluation of treatment for recurrent stenosis 
should compare angioplasty with carotid reoperation 
as currently performed, rather than reference series 
reported a decade ago. Furthermore, because of the 
early benign course of this condition, any evaluation 
of therapeutic ntervention for recurrent carotid ste- 
nosis should include a control group of patients who 
do not undergo peration. 
What, then, can one conclude about the appro- 
priate treatment of recurrent carotid disease? Clearly, 
the efforts to prevent this problem must continue to 
be emphasized. These include extensive ndarterec- 
tomy, liberal use of patch closure, and aggressive risk 
factor modification to retard the progression of ath- 
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erosclerosis. Performance of a technically flawless op- 
eration also appears to influence the incidence of late 
recurrence, and any methods that serve that end, 
including completion imaging, are appropriate. As 
indicated in our prior publication, we believe that 
periodic duplex follow-up to detect recurrent steno- 
ses is appropriate--currently, patients who have nor- 
mal study results are followed-up every 2 years. 
Those in whom abnormalities develop are fol- 
lowed-up every 6 months. If recurrent lesions occur, 
one must remember that the majority of these lesions 
will remain asymptomatic for 5 years or more. There- 
fore, routine repair of  such lesions does not appear to 
be justified. Asymptomatic recurrent stenoses in pa- 
tients who have multiple medical comorbidities or a 
limited life expectancy can be observed, as most will 
remain asymptomatic. Similarly, asymptomatic re- 
currences that would present particular technical 
challenges (i.e., high lesions, multiple recurrences) 
need not be repaired unless symptoms supervene. 
However, our initial reluctance to reoperate on any 
asymptomatic lesion appears unjustified, particularly 
in view of the increased late stroke risk in these 
patients and the fact that operation was ultimately 
required in almost half of our patient group. We now 
consider reoperation for asymptomatic recurrent ste- 
noses for good-risk patients who have a significant 
life expectancy. This should receive particular consid- 
eration if recurrence is in the proximal common 
carotid artery. The role of  endovascular therapy in 
this disease remains to be defined by controlled trials. 
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DISCUSSION 
Dr. Robert W. Hobson I I  (Newark, N.J.). Dr. 
Ricotta has reviewed ata on 348 carotid endarterectomy 
procedures performed between 1982 and 1996. I would 
caution you that although the data are studied with great 
care, the number of recurrent lesions is relatively small. 
There were 13 residual lesions (an incidence of 3.7%) and 
23 restenotic lesions (an incidence of 6.6%). In addition, 
the definition in the manuscript ofresidual lesion included 
those patients with stenoses identified up to 1 year after 
operation. Is it possible that some of the residual lesions 
actually were early myointimal hyperplastic lesions rather 
than residual lesions? And if that's possible, how would it 
have affected your analysis? 
Secondly, a residual lesion may be of significance in 
terms of subsequent development of stroke. Consequently, 
I would like your opinion with regard to its identification 
during the operation. What are your recommendations  
the use of imaging techniques or intraoperative angiogra- 
phy to identify a residual lesion, thereby allowing intraop- 
erative correction rather than delayed management? 
Another area of interest was the restenotic lesion. They 
are of great interest to us, and your data regarding ender 
and patching were useful. I would be interested in your 
comments on recommendations for use of carotid patches. 
What patches are you currently using? Three quarters of 
your patients were patched, and yet you report a substan- 
tial number of restenoses. What was the distribution of 
restenoses in the patched group versus those closed pri- 
marily? 
One of the most interesting aspects of this paper was 
the progression of contralateral disease identified in the 
group with restenosis. This observation has not been well 
documented in the literature. What are your thoughts as to 
the etiologic mechanism? How are ipsilateral restenoses 
and atherosclerotic progression in a contralateral rtery 
related? 
Finally, because the incidence of cranial nerve palsies 
after operations for restenosis remain higher than reported 
for initial procedures, i  carotid angioplasty and stenting an 
option in managing these patients? 
I enjoyed this paper. It presents a number of important 
issues that will stimulate additional study. 
Dr. John J. Ricotta. I agree with your first point 
about early recurrence versus restenosis. Because this was a 
long time period and we didn't have a routine duplex 
protocol in the early part of the study, we had to make 
some arbitrary distinctions. It is certainly possible that 
some of these residual lesions may have been early recur- 
rences. That is part of the reason that when I looked at the 
late stroke rate I tried to group those two lesions together. 
It had to be the patient's first postoperative duplex scan 
that was abnormal. Now, unfortunately, there were a cou- 
ple of patients who didn't undergo their first postoperative 
duplex scan until 6 to 8 months after the operation. Be- 
cause they had a lesion, I didn't know where to put them, 
so I made this definition. 
I think your point about identifying these lesions dur- 
ing the operation is extremely important. Now we don't 
perform routine imaging. I can tell you, I went back and 
looked at the operation otes on my patients who had 
these internal lesions because I was very concerned about 
this. These were all people who had very high lesions. My 
approach as been that ifI have done the best I can do, I 'm 
not sure I want to see an angiogram because it can't be 
improved. I mean, many of these stenoses were up above 
the hypoglossal nerve, and further epair would be difficult. 
I have a couple of patients in whom I have performed 
saphenous vein interposition and have had a stenosis dis- 
tally. And I think that that's a technical problem. We're a 
little bit comforted by the fact that they haven't been 
symptomatic, but certainly it's disturbing to have these 
lesions. 
In the common carotid lesion, I don't think you're 
going to do anything with completion imaging because it's 
going to be below where you're going to do your anglo- 
gram. However, the data that Dr. Bandyk mentioned relat- 
ing residual disease and the development of late recurrence 
is concerning tome. It may be that that's probably the best 
reason to do some sort ofa coi~pletion study, whether it's 
a duplex scan or an angiogram. If you can reduce your rate 
of recurrence stenoses by performing duplex surveillance in 
the operating room, that may be useful. Our rate is about 
what everybody else's rate is, but certainly at 6.6% there is 
room for improvement. 
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We currently use external jugular vein preferentially. I 
will use Hemashield. There was some polytetrafluoroethyl- 
ene used in this study. We could not correlate patch mate- 
rial with rate of restenosis, but it wasn't a prospective, 
randomized study. And as you know, Dr. AbuRahma has 
done a study like that and reported it here. There was a 
lower incidence of restenosis in the patcl~ed group. I think 
Dr. Green and several other people have reported that 
there is a lower incidence of restenosis n patching. This 
data set would not answer that question because my prac- 
tice progressed in a way where most of my unpatched 
patients were early in my practice and most of my patched 
patients were later, and I hope I learned how to do an 
endarterectomy better as I got more mature. So I can't 
make any comments about my own data. 
I think that myointimal hyperplasia s less important 
than progressive atherosclerosis, and I think our data with 
contralateral progression confirmed my prejudice that the 
people who were coming back, at least for symptomatic 
recurrences, were people who had very, very aggressive 
atherosclerosis. I think we've got to work on keeping these 
people from smoking, we've got to work on their lipids and 
that sort of business, and I think we don't pay enough 
attention to that. 
I have sent one patient for angioplasty with stenting, 
and it is a patient with a recurrent carotid stenosis. It's a 
second-time r currence that is very high and very severe. I 
thought hat this patient might benefit. I think that if 
endovascular procedures are going to be useful it will be in 
this type of patient. My concern is that they not be rou- 
tinely recommended in asymptomatic patients with recur- 
rence. I think that we need to know what the rate of 
complications are both for surgery and for endovascular 
procedures before we recommend them as a routine pro- 
cedure in asymptomatic patients because so many of these 
people with recurrent stenosis will in fact remain asymp- 
tomatic for a number of years. 
Dr. Luis A. Queral (Baltimore, Md.). In spite of the 
presented large series, the number of recurrent carotid 
stenoses i quite small. This would explain why the rest of 
us see relatively small numbers of these patients. Conse- 
quently, it's hard to decide what to do with the patients. 
However, when I note the high incidence of cranial nerve 
palsies and an 18% stroke rate when operating on these 
patients, an alternative ndovascular pproach as to be 
considered. This new approach would encompass a small 
surgical cutdown in the cervical common carotid artery and 
treatment ofthe offending lesion with minimal dissection. 
I am troubled by the small number of these patients 
and find it difficult to determine whether managing the 
recurrences u ing a standard surgical technique or by using 
an endovascular pproach is optimal. I would like your 
comments on this matter, because itappears to me that this 
issue will not be resolved unless a multicenter p ospective 
cooperative study can be instituted. 
Dr. Ricotta. I would agree with you, Dr. Queral. I
think that's the only way that it's going to be accom- 
plished. The largest series that I could find in the literature 
on this was Dr. Clagett's eries of 70 patients. So there is 
nobody who had a big series of patients who has reported 
on it. 
I think that the questions are exactly as you outlined 
them. Is endovascular therapy better than surgery? And I 
would add a third arm, and that is observing the patients 
who are asymptomatic. So I think ultimately, if we're going 
to decide truly the right way to take care of these patients, 
that we need to compare the two forms of intervention i
symptomatic patients, and then in asymptomatic patients 
compare those two forms of intervention with observation. 
The interest that we had here was that we were com- 
mitted to not operating on these patients. I wanted to see 
what would happen. There is not a lot in the literature to 
tell us what the natural history of these lesions is if you are 
committed to observe them for long periods of time. Most 
of the series, even though I'm sure there are patients that 
have been observed, haven't reported separately on those 
patients. Maybe this is something that the Registry Com- 
mittee in this Society can do. If we got the collective 
experience in a prospective fashion with recurrent stenoses 
of 500 people that perform vascular surgery, or even got 
half of those people, to randomize their patients into vari- 
ous treatment options, we may be able to add something 
to a literature that has no series of a hundred patients in it. 
Dr. Paul Gagne (Chesapeake, Va.). I have a quick 
question for Dr. Ricotra. Many of the series on recurrent 
stenosis evaluate all stenotic lesions >50%. I was wonder- 
ing whether you got a sense in this study whether the 
stenotic lesions that were more midrange, 50% to 79%, say, 
behaved differently than lesions that were more high- 
grade? 
Dr. Ricotta. I think in our first report, we found that 
none of the moderate lesions led to symptoms. Now, 
subsequently we've had a couple of patients who started 
out with a moderate l sion and eventually had symptoms. 
There are only two or three of them, and I have to be 
honest with you, I can't tell you whether they had pro- 
gressed when the symptoms developed or not. My preju- 
dice is that that's probably what was happening, that they 
had a moderate lesion, we followed them up for a pro- 
longed period of time, and they showed some progression, 
and it would fit with the thesis of atherosclerosis. 
The real question to me is when you have an 80% 
lesion, do you watch it or do yon intervene? I 'm not 
convinced that my policy of watching is always the right 
thing to do, so I 'm more inclined now to intervene insome 
way, whether it's endovascular or operative. 
Dr. Richard M. Green (Rochester, N.Y.). I enjoyed 
your paper, and it sounds to me that you started out with a 
very conservative approach and have moved to an aggres- 
sive approach, which I would agree with. We have been 
struck over the past few years that an inordinate number of 
these cases are neither atherosclerotic or intimal hyperplas- 
tic, but they are this florid thrombotic process that occurs 
in the endarterectomized 'bulb. For that reason, we have 
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been very aggressive in treating these patients, not with 
conventional reendarterectomy, butwith exclusion bypass 
grafting. By approaching the carotid artery very low and 
very high through a lateral approach, the original operative 
site is not disturbed, and the number ofemboli and cranial 
nerve palsies have been reduced. So I would caution that 
(1) I think recurrent carotid disease is significant; (2) a 
number of the lesions are gross thrombus, and one should 
not treat them with endovascular p ocedures; and (3) an 
aggressive approach iswarranted. 
Dr. Enrico Ascher (Brooklyn, N.Y.). I very much 
enjoyed your presentation. I have a couple of questions 
that maybe you can clarify for me. Where is the exact site of 
the restenosis? Is it the bulb? Is it distal internal carotid 
artery? Is it in the proximal internal carotid artery? Because 
that may have some clinical implications. If it's in the 
common carotid artery, it may not be as bad to just watch 
them, even with severe stenosis. We really don't know what 
the natural history of these lesions is. Certainly, in the bulb 
we may have some clinical implications in terms of using a 
patch or not. I have noticed that those that I have seen in 
terms of restenosis have been tight at the bulb, and these 
patients have had patches before. So I 'm not so sure the 
patch is as protective as we think. 
My second question relates to residual problems. Is 
that a residual plaque, or this is a stenosis repair that was 
performed by poor technique? Maybe the natural history 
of those lesions is quite different, and I wonder whether 
you can shed some light on these questions. 
Dr. Ricotta. First, Dr. Green, I agree with you. We've 
started to do some interposition grafting the last couple 
that I've done. The one problem is that it is very difficult o 
use a shunt in those patients, at least in my experience, 
when you do that. In fact, the patient who had the deficit 
had crescendo transient ischemic attacks, and we tried to 
figure out a way to put a shunt in and we couldn't. We used 
an interposition graft in him, and we put the shunt in once 
we'd gotten the distal anastomosis done through the vein 
graft, but it was a problem. So I think that's a very good 
technique, and I've used it. I think it simplifies the opera- 
tion. 
Dr. Ascher, the stenoses were widely distributed. I 
thought I was going to find them all in one place, and I 
didn't. There is no question that there are some patients 
who had a distal stenosis where either I didn't sew it in 
correctly or there was a clamp problem distally. But there is 
no question that about a third of the patients had a stenosis 
at the distal end point. Now, some of those patients were 
not patched, and I think that patch helps there. There were 
some bifurcation stenoses, and I think that this has to do 
with what Dr. Green is talking about, and it may be that a 
big patch may be a problem because it may collect hrom- 
bus and may stimulate hyperplasia. There were a few peo- 
ple with proximal common carotid lesions. 
Now, I would suggest to you that a proximal common 
carotid lesion is a big problem. I think Drs. Green and 
Ouriel reported this at the national meetings about 6 or 7 
years ago, in which they followed-up a number of these 
patients and they had a very high incidence of recurrent 
stenoses. So if I see a proximal lesion that I think is 
atherosclerofic, I 'm very aggressive about going back to 
get that. And I wouldn't leave the proximal lesions alone. I
would probably fix the middle lesions. What you do with 
the distal lesions, I think, is sometimes very difficult be- 
cause in our situation we've already gone usually as high as 
we can go without subluxation of the mandible and that 
sort of business, and I am very hesitant in an asymptomatic 
patient o go back and reoperate on those. Performing 
balloon angioplast~ in those patients and putting a stent in 
may be correct. 
